malERA: An updated research agenda for health systems and policy research in malaria elimination and eradication
Marcel Tanner and colleagues examine progress in health systems and policy research for malaria elimination and eradication.
Vyšlo v časopise:
malERA: An updated research agenda for health systems and policy research in malaria elimination and eradication. PLoS Med 14(11): e32767. doi:10.1371/journal.pmed.1002454
Kategorie:
Collection Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002454
Souhrn
Marcel Tanner and colleagues examine progress in health systems and policy research for malaria elimination and eradication.
Zdroje
1. WHO. WHO World Malaria Report 2015. Geneva, Switzerland; 2015.
2. The malERA Consultative Group on Health Systems and Operational Research. A research agenda for malaria eradication: health systems and operational research. PLoS Med. 2011;8(1):e1000397. doi: 10.1371/journal.pmed.1000397 21311588
3. Research WAfHPaS. Systems Thinking for Health Systems Strengthening. 2009.
4. WHO. Global Technical Strategy for malaria 2016–2030 WHO. Geneva, Switzerland; 2015.
5. WHO. Action and Investment to Defeat Malaria 2016–2030. 2015.
6. Malaria Eradication Scientific MESA. Available from: http://www.malariaeradication.org/. Cited 29 Sept 2017.
7. WHO. Malaria Policy Advisory Committee Available from: http://www.who.int/malaria/mpac/en/. Cited 29 Sept 2017.
8. WHO. Scaling up research and learning for health systems: now is the time. WHO, Geneva; 2008.
9. MESA Track database: Malaria Eradication Scientific Alliance (MESA); [Database]. Available from: http://www.malariaeradication.org/mesa-track. Cited 29 Sept 2017.
10. Hadorn GH, Pohl C. Principles for Designing Transdisciplinary Research. Munic, Germany: oekom verlag; 2007.
11. Delbecq AL, Van deVEn AH. A Group Process Model for Problem Identification and Program Planning. Journal of Applied Behavioral Science. 1971;7:466–92.
12. Vlassoff C, Tanner M. The relevance of rapid assessment to health research and interventions. Health Policy and Planning. 1992;7(1):1–9.
13. The malERA Refresh Consultative Panel on Combination Interventions and Modelling. malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication. PLoS Med. 2017;14(11):e1002453. https://doi.org/10.1371/journal.pmed.1002453
14. Whittaker M, Smith C, Mouzin E. The Asia Pacific Malaria Elimination Network: Supporting the common goal of a malaria free Asia Pacific. Geneva, Switzerland; 2014.
15. E8, the eight eliminating southern African countries. “Malaria Elimination 8 (E8)”. Available from: https://malariaelimination8.org/. Cited 29 Sept 2017.
16. African Leaders Malaria Alliance. Available from:http://alma2030.org/. Cited 29 Sept 2017.
17. Asia Pacific Leaders Malaria Alliance. Available from: http://www.aplma.org. Cited 29 Sept 2017.
18. Evans DB, Etienne C. Health systems financing and the path to universal coverage. Bull World Health Organ. 2010;88(6):402. doi: 10.2471/BLT.10.078741 20539847
19. Rittel H, Webber M. Dilemmas in a General Theory of Planning. Policy Science. 1973;4:155–69.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2017 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
- HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project
- Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study
- Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial